CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells

Ariunbold Natsagdorj(Kanazawa University), Atsushi Mizokami(Kanazawa University)
Cancer Science
November 14, 2018
Cited by 57


Related Papers